Home
Account
Research Tools & Data
Educate
Contribute
News
ETFs
Sectors
About
Subscribe
Login
Manage Account
Quote and Research
Stock Charts
Earnings Calendar
Technical Scans
Economic Calendar
Chart School
Tutorials
Learning Center
Submit Article
Join Blog Network
Chat Rooms
Rate Broker
Rate Software
About Us
Contact Us
Advertise With Us
Terms and Conditions
Enter Symbol
Overview
Community Research
Stock Sentiment
Whisper Estimates
Enter Estimates
Company Profile
Technical Charts
Competitors
Analyst Ratings
Analyst Estimates
Sales Estimates
Related News
Blog Articles
Press Releases
Message Board
Option Chain
Financial Ratios
Technicals
SEC Filings
Sector: Medical
PLX (AMEX: PLX)
3m
6m
1y
2y
Ranking History
This Week
Last Week
Two Weeks Back
Three Weeks Back
Please login to view our current ranking data
Click here to login
No Information
No Information
No Information
Disclaimer
Headlines
Blog Articles
Press Releases
SEC
Reversal Session?
Nov 12, 2009 09:33 PM |
AAPL
,
AMD
,
GNK
,
GS
,
INTC
,
KONG
Support Holds As Indices Eek Out More Gains
Nov 11, 2009 06:18 PM |
AIG
,
CAAS
,
DRYS
,
EXM
,
GNK
,
GS
Protalix BioTherapeutics to Present at the Oppenheimer 20th Annual Healthcare Conference
Oct 29, 2009 07:30 AM |
PLX
CORRECTING and REPLACING Protalix BioTherapeutics Announces Positive Top-line Results from its Phase III Clinical Trial of UPLYSO(TM) for the Treatment of Gaucher Disease
Oct 15, 2009 08:37 AM |
PLX
Protalix BioTherapeutics Announces Positive Top-line Results from its Phase III Clinical Trial of UPLYSO(TM) for the Treatment of Gaucher Disease
Oct 15, 2009 06:00 AM |
PLX
Protalix Reports Preclinical Data on Anti-TNF Follow-on Biologic Arthritis Drug
Sep 22, 2009 07:30 AM |
PLX
Protalix Completes Pivotal Phase III Trial for prGCD for the Treatment of Gaucher Disease
Sep 14, 2009 08:01 AM |
PLX
FDA Grants Protalix Orphan Drug Designation for prGCD
Sep 08, 2009 07:30 AM |
PLX
Protalix Receives FDA Fast Track Designation for prGCD
Aug 25, 2009 08:00 AM |
PLX
U.S. Food and Drug Administration Approves Protalix's Treatment Protocol for prGCD
Aug 17, 2009 07:30 AM |
PLX
More..
More..
Protalix BioTherapeutics to Present at Three Upcoming Healthcare Conferences
Aug 06, 2009 08:41 AM |
PLX
Protalix Holds Pre-NDA Meeting with FDA for prGCD
Jul 14, 2009 08:26 AM |
PLX
Protalix Approached by the FDA to Consider Submitting a Treatment Protocol for the Use of prGCD in Patients with Gaucher Disease Allowing Expanded Access to prGCD
Jul 06, 2009 07:31 AM |
PLX
Protalix Initiates a Home Care Treatment Program for Gaucher Patients in the Phase III Extension Trial of prGCD
Jun 25, 2009 08:33 AM |
PLX
Frost & Sullivan Presents Protalix Biotherapeutics with its 2009 European Orphan Diseases Market Product Innovation of the Year Award
Jun 04, 2009 07:32 AM |
PLX
Protalix BioTherapeutics to Present at Three Upcoming Healthcare Conferences
Jun 01, 2009 07:32 AM |
PLX
Protalix BioTherapeutics to Participate in Three International Healthcare Conferences
May 12, 2009 09:26 AM |
PLX
Protalix BioTherapeutics Receives Research Grant of over $6 Million from the Israeli Government’s Office of the Chief Scientist
Mar 11, 2009 09:17 AM |
PLX
Protalix BioTherapeutics to Participate in the Credit Suisse Global Biotechnology, Biopharma and Generics One-on-One Conference
Feb 26, 2009 05:31 PM |
PLX
Protalix BioTherapeutics to Present at the WORLD Lysosomal Disease Network Symposium 2009
Feb 13, 2009 07:31 AM |
PLX
More..
Form 4 Protalix BioTherapeutics For: Nov 12 Filed by: Hurvitz Eli (10K)
Nov 13, 2009 05:14 PM
Form 4 Protalix BioTherapeutics For: Oct 19 Filed by: Aviezer David (10K)
Oct 21, 2009 09:42 PM
Form 4 Protalix BioTherapeutics For: Oct 15 Filed by: Almon Einat Brill (10K)
Oct 19, 2009 10:30 PM
Form 4 Protalix BioTherapeutics For: Oct 15 Filed by: Shaaltiel Yoseph (10K)
Oct 19, 2009 10:26 PM
Form 4 Protalix BioTherapeutics For: Oct 15 Filed by: Maimon Yossi (10K)
Oct 19, 2009 10:24 PM
Form 4 FROST PHILLIP MD ET AL For: Sep 09 (10K)
Sep 11, 2009 02:23 PM
Form 4 FROST PHILLIP MD ET AL For: Sep 01 (10K)
Sep 03, 2009 09:34 PM
Form 4 FROST PHILLIP MD ET AL For: Aug 24 (10K)
Aug 26, 2009 09:09 PM
Form 4 FROST PHILLIP MD ET AL For: Aug 20 (10K)
Aug 21, 2009 08:34 PM
Form 4 FROST PHILLIP MD ET AL For: Aug 18 (10K)
Aug 19, 2009 09:02 PM
More..
Analyst Ratings
More Details
Sentiment Survey
Avg. Short Term
Avg. Long Term
Avg. Grade
More Details
Share Performance
Period
PLX
Compare to S&P
YTD
444.02 %
350.24 %
4 Weeks
18.60 %
17.32 %
12 Weeks
67.39 %
57.81 %
More...
Financial Ratios
Earnings Performance
EPS Growth in Last Quarter:
25.00 %
EPS Growth in Last Year:
-28.57 %
Sales Growth in Last Quarter:
-0.01 %
Sales Growth in Last Quarter:
-0.01 %
More...
{1}
##LOC[OK]##
{1}
##LOC[OK]##
##LOC[Cancel]##
{1}
##LOC[OK]##
##LOC[Cancel]##
Fundamental data is provided by
Zacks Investment Research
, market data is provided by
AlphaTrade.
, and Commentary and Press Releases provided by
Quotemedia
